VCNX · CIK 0001205922

Vaccinex, Inc.

Annual figures as reported, FY2016–FY2024. Ratios and growth rates derived on-page.

Revenue

$601K

▲ +5.4% vs FY2023

Net income

−$18.6M

▲ +8.0% vs FY2023

Free cash flow

−$16.2M

▲ +24.4% vs FY2023

Diluted EPS

−$8.88

▲ +79.7% vs FY2023

Revenue

Annual, as reported

Net income

Losses shown in terracotta

Recent quarters

momentum · last 12 quarters

Revenue — Dec ’24 quarter

$213K

Net income — Dec ’24 quarter

−$3.4M

▼ −1.7% vs Dec ’23

Revenue — trailing 12 months

$601K

Diluted EPS — trailing 12 months

−$8.88

▲ +79.7% vs Dec ’23

Quarterly revenue

Discrete quarters; Q4 derived from the annual figure

Quarterly net income

Losses shown in terracotta

Quarter	Revenue	Rev. YoY	Gross margin	Net income	Net margin	Diluted EPS
Dec ’24	$213K	—	—	−$3.4M	−1584.0%	−$0.01
Sep ’24	$52K	160.0%	—	−$5.7M	−11023.1%	−$2.83
Jun ’24	$232K	—	—	−$5.6M	−2427.2%	−$3.10
Mar ’24	$104K	−81.1%	—	−$3.9M	−3747.1%	−$2.94
Sep ’23	$20K	−60.0%	—	−$4.9M	−24560.0%	−$15.25
Mar ’23	$550K	—	—	−$5.0M	−902.2%	−$20.89
Sep ’22	$50K	0.0%	—	−$4.8M	−9518.0%	−$1.67
Sep ’21	$50K	−92.0%	—	—	—	—

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

Operating marginNet margin

Returns on capital

Net income vs year-end equity and assets

Return on equityReturn on assets

Cash flow

cash generation

Free cash flow

Operating cash flow less capital expenditure

Operating cash flow

Net cash from operations

Shareholder returns

capital allocation

Diluted shares outstanding

Falling count means buybacks outpace dilution

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

Net debt

Long-term debt less cash — negative means net cash

Growth rates

compounding, annualized

Revenue CAGR

−12.6%

+2.8%

Key ratios

derived per fiscal year

Fiscal year	Op. margin	Net margin	FCF margin	ROE	ROA	Current ratio	Debt / equity
FY2024	−3117.3%	−3100.5%	−2696.8%	—	−717.8%	0.50×	—
FY2023	−4014.9%	−3552.8%	−3762.5%	—	−557.7%	0.57×	—
FY2022	−7238.5%	−7205.5%	−6972.0%	−381.6%	−248.4%	2.95×	0.02×
FY2021	−2498.9%	−2486.7%	−2814.4%	−301.9%	−227.4%	4.17×	0.02×
FY2020	−4533.0%	−4616.2%	−4629.9%	—	−246.5%	0.86×	—
FY2019	−6121.4%	−6092.4%	−5887.8%	—	−692.1%	0.58×	—
FY2018	−3768.1%	−4077.1%	−3523.6%	—	−134.0%	3.20×	—
FY2017	−23448.9%	−20802.2%	−23838.9%	—	−335.8%	1.19×	—
FY2016	—	—	—	—	—	—	—

Annual figures

as reported

Fiscal year	Revenue	Gross profit	Op. income	Net income	Diluted EPS	Op. cash flow	Capex	Total assets	Liabilities	Equity	Cash	LT debt
FY2024	$601K	—	−$18.7M	−$18.6M	−$8.88	−$16.2M	$22K	$2.6M	$5.1M	−$2.5M	$1.1M	$0
FY2023	$570K	—	−$22.9M	−$20.3M	−$43.68	−$21.4M	$67K	$3.6M	$5.9M	−$2.3M	$1.5M	$26K
FY2022	$275K	—	−$19.9M	−$19.8M	−$98.05	−$19.1M	$99K	$8.0M	$2.8M	$5.2M	$6.4M	$101K
FY2021	$900K	—	−$22.5M	−$22.4M	−$0.78	−$25.3M	$32K	$9.8M	$2.4M	$7.4M	$8.6M	$175K
FY2020	$625K	—	−$28.3M	−$28.9M	−$1.54	−$28.6M	$290K	$11.7M	$14.3M	−$26.6M	$10.6M	$1.1M
FY2019	$523K	—	−$32.0M	−$31.9M	−$2.47	−$30.7M	$78K	$4.6M	$6.9M	−$26.2M	$2.8M	—
FY2018	$724K	—	−$27.3M	−$29.5M	−$5.65	−$25.3M	$235K	$22.0M	$6.7M	−$8.6M	$5.6M	—
FY2017	$90K	—	−$21.1M	−$18.7M	−$19.90	−$21.4M	$68K	$5.6M	$7.3M	−$125.5M	$4.2M	$4.0M
FY2016	—	—	—	—	—	—	—	—	—	−$107.1M	$1.7M	—

Latest filings

the most recent regulatory filings

10-KAnnual report2025-04-15 ↗NT 10-KSEC filing2025-04-01 ↗15-12GSEC filing2025-03-27 ↗EFFECTSEC filing2025-03-25 ↗EFFECTSEC filing2025-03-25 ↗EFFECTSEC filing2025-03-25 ↗EFFECTSEC filing2025-03-25 ↗EFFECTSEC filing2025-03-25 ↗EFFECTSEC filing2025-03-25 ↗EFFECTSEC filing2025-03-25 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.

Quarter

Revenue

Rev. YoY

Gross margin

Net income

Net margin

Diluted EPS

Dec ’24

$213K

—

−$3.4M

−1584.0%

−$0.01

Sep ’24

$52K

160.0%

—

−$5.7M

−11023.1%

−$2.83

Jun ’24

$232K

—

−$5.6M

−2427.2%

−$3.10

Mar ’24

$104K

−81.1%

—

−$3.9M

−3747.1%

−$2.94

Sep ’23

$20K

−60.0%

—

−$4.9M

−24560.0%

−$15.25

Mar ’23

$550K

—

−$5.0M

−902.2%

−$20.89

Sep ’22

$50K

0.0%

—

−$4.8M

−9518.0%

−$1.67

Sep ’21

$50K

−92.0%

—

Fiscal year

Op. margin

Net margin

FCF margin

ROE

ROA

Current ratio

Debt / equity

FY2024

−3117.3%

−3100.5%

−2696.8%

—

−717.8%

0.50×

—

FY2023

−4014.9%

−3552.8%

−3762.5%

—

−557.7%

0.57×

—

FY2022

−7238.5%

−7205.5%

−6972.0%

−381.6%

−248.4%

2.95×

0.02×

FY2021

−2498.9%

−2486.7%

−2814.4%

−301.9%

−227.4%

4.17×

0.02×

FY2020

−4533.0%

−4616.2%

−4629.9%

—

−246.5%

0.86×

—

FY2019

−6121.4%

−6092.4%

−5887.8%

—

−692.1%

0.58×

—

FY2018

−3768.1%

−4077.1%

−3523.6%

—

−134.0%

3.20×

—

FY2017

−23448.9%

−20802.2%

−23838.9%

—

−335.8%

1.19×

—

FY2016

—

Fiscal year

Revenue

Gross profit

Op. income

Net income

Diluted EPS

Op. cash flow

Capex

Total assets

Liabilities

Equity

Cash

LT debt

FY2024

$601K

—

−$18.7M

−$18.6M

−$8.88

−$16.2M

$22K

$2.6M

$5.1M

−$2.5M

$1.1M

FY2023

$570K

—

−$22.9M

−$20.3M

−$43.68

−$21.4M

$67K

$3.6M

$5.9M

−$2.3M

$1.5M

$26K

FY2022

$275K

—

−$19.9M

−$19.8M

−$98.05

−$19.1M

$99K

$8.0M

$2.8M

$5.2M

$6.4M

$101K

FY2021

$900K

—

−$22.5M

−$22.4M

−$0.78

−$25.3M

$32K

$9.8M

$2.4M

$7.4M

$8.6M

$175K

FY2020

$625K

—

−$28.3M

−$28.9M

−$1.54

−$28.6M

$290K

$11.7M

$14.3M

−$26.6M

$10.6M

$1.1M

FY2019

$523K

—

−$32.0M

−$31.9M

−$2.47

−$30.7M

$78K

$4.6M

$6.9M

−$26.2M

$2.8M

—

FY2018

$724K

—

−$27.3M

−$29.5M

−$5.65

−$25.3M

$235K

$22.0M

$6.7M

−$8.6M

$5.6M

—

FY2017

$90K

—

−$21.1M

−$18.7M

−$19.90

−$21.4M

$68K

$5.6M

$7.3M

−$125.5M

$4.2M

$4.0M

FY2016

—

−$107.1M

$1.7M

—